Skip To Main Content
Poojarani Panda on Muck Rack

Poojarani Panda

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Poojarani

Contact Poojarani, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Onco | Free Full-Text | Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies

|
By Poojarani Panda, Henu Kumar Verma, Henu Kumar
| MDPI
1. Introduction Esophageal carcinoma (EC) is a malignant disease with devastating effects. It is the ninth most common cancer and ranks as the sixth leading cause of cancer-related deaths worldwide [1]. EC, which includes esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), is a kind of cancer that develops in the esophagus [2]. If it occurs in the middle or upper portion, EC can be fatal [3]. The male-to-female ratio is 3:1 for ESCC, while for EAC, it is 6:1.
Open in Who Shared Issue with article?
See all 1 articles